Design Therapeutics Aktie
WKN DE: A2QR0A / ISIN: US25056L1035
17.04.2025 14:56:48
|
Design Therapeutics Names Chris Storgard Chief Medical Officer
(RTTNews) - Design Therapeutics, Inc. (DSGN) Thursday said it has appointed Chris M. Storgard as Chief Medical Officer (CMO).
Storgard has more than two decades experience in drug development including successful advancement of drugs from preclinical stages to global regulatory approvals.
Most recently, he was the the CMO at ADARx Pharmaceuticals, where he oversaw the advancement of multiple clinical programs, including preparations for the company's first global Phase 3 program.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Design Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Design Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Design Therapeutics Inc Registered Shs | 3,84 | -1,79% |
|